Combined PET/MRS brain studies show dynamic and long-term physiological changes in a primate model of Parkinson disease (original) (raw)

• Gjaedde, A. & Wong, D.F. Modeling neuroreceptor binding of radioligands in vivo. Quant. Imaging 51– 79 (1990).
• Delforge, J. et al. Kinetic analysis of central (76)bromolisuride binding to dopamine D2-receptors studied by PET. J. Cereb. Blood Flow Metab. 11, 914–925 ( 1991).
  Article CAS Google Scholar
• Leenders, K.L. Pathophysiology of movement disorders studied using PET. J. Neural Transm. Suppl. 50, 39–46 (1997).
  Article CAS Google Scholar
• Cruz, C.J., Aminoff, M.J., Meyerhoff, D.J., Graham, S.H. & Weiner, M.W. Proton MR spectroscopic imaging of the striatum in Parkinson's disease. Magn. Reson. Imaging 15, 619–624 (1997).
  Article CAS Google Scholar
• Holshouser, B.A. et al. Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study. Magn. Reson. Imaging 33, 589–594 (1995).
  CAS Google Scholar
• Brooks, D.J. PET studies on the early and differential diagnosis of Parkinson's disease. Neurology 43, S6–S16 (1993).
  CAS PubMed Google Scholar
• Herholz, K. et al. In vivo imaging of glucose consumption and lactate concentration in human gliomas. Ann. Neurol. 31, 319–327 (1992).
  Article CAS Google Scholar
• Alger, J.R., Frank, J.L., van Zijl, P.C., Moonen, C.T. & DiChiro, G. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 177, 633–641 ( 1990).
  Article CAS Google Scholar
• Hugg, J.W. et al. Elevated lactate and alkalosis in chronic human brain infarction observed by 1H and 31P MR spectroscopic imaging. J. Cereb. Blood Flow Metab. 12, 734–744 (1992).
  Article CAS Google Scholar
• Petroff, O.A. et al. Spectroscopic imaging of stroke in humans: histopathology correlates of spectral changes. Neurology 42, 1349–1354 (1992).
  Article CAS Google Scholar
• Prichard, J. et al. Lactate rise detected by 1H NMR in human visual cortex during physiologic stimulation. Proc. Natl. Acad. Sci. USA 88, 5829–5831 (1991).
  Article CAS Google Scholar
• Schapira, A.H. Pathogenesis of Parkinson's disease. Baillieres Clin. Neurol. 6, 15–36 (1997).
  CAS PubMed Google Scholar
• Frost, J.J. et al. Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann. Neurol. 34, 423–431 (1993).
  Article CAS Google Scholar
• Ehringer, H. & Hornykiewicz, O. Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Klin. Wochenschr. 38, 1236–1239 (1960).
  Article CAS Google Scholar
• Dunnett, S.B., Whishaw, I.Q., Jones, G.H. & Isacson, O. Effects of dopamine-rich grafts on conditioned rotation in rats with unilateral 6-hydroxydopamine lesions. Neurosci. Lett. 68, 127–135 (1986).
  Article CAS Google Scholar
• Ungerstedt, U. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur. J. Pharmacol. 5, 107–110 (1968).
  Article CAS Google Scholar
• Langston, J.W., Langston, E.B. & Irwin, I. MPTP-induced parkinsonism in human and non-human primates—clinical and experimental aspects. Acta Neurol. Scand. Suppl. 100, 49–54 (1984).
  CAS PubMed Google Scholar
• Calne, D.D. et al. Positron emission tomography after MPTP. Nature 317, 244–248 ( 1985).
  Article Google Scholar
• Burns, R.S. et al. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by n-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 80, 4546– 4550 (1983).
  Article CAS Google Scholar
• Hantraye, P. et al. In vivo visualization by positron emission tomography of the progressive striatal dopamine receptor damage occuring in MPTP-intoxicated non-human primates. Life Sci. 39, 1375– 1382 (1986).
  Article CAS Google Scholar
• Imai, H., Nakamura, T., Endo, K. & Narabayashi, H. Hemiparkinsonism in monkeys after unilateral caudate nucleus infusion of 1-methyl-4-phenyl-1,2,3,6-tetrapyridine (MPTP): behavior and histology. Brain Res. 474, 327–338 (1988).
  Article CAS Google Scholar
• Hantraye, P. et al. Dopamine fiber detection by [11 C]-CFT and PET in a primate model of parkinsonism. Neuroreport 3, 265 –268 (1992).
  Article CAS Google Scholar
• Wullner, U. et al. Dopamine terminal loss and onset of motor symptoms in MPTP-treated monkeys: a positron emission tomography study with 11C-CFT. Exp. Neurol. 126, 305–309 ( 1994).
  Article CAS Google Scholar
• Temlett, J.A. Parkinson's disease: biology and aetiology. Curr. Opin. Neurol. 9, 303–307 ( 1996).
  Article CAS Google Scholar
• Frohna, P.A., Rothblat, D.S., Joyce, J.N. & Schneider, J.S. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism. Synapse 19, 46–55 (1995).
  Article CAS Google Scholar
• Strauss, I., Williamson, J.M., Bertram, E.H., Lothman, E.W. & Fernandez, E.J. Histological and 1H magnetic resonance spectroscopic imaging analysis of quinolinic acid-induced damage to the rat striatum. Magn. Reson. Med. 37, 24–33 (1997).
  Article CAS Google Scholar
• Higuchi, T. et al. Effects of severe global ischemia on N-acetylaspartate and other metabolites in the rat brain. Magn. Reson. Med. 37, 851–857 (1997).
  Article CAS Google Scholar
• Jenkins, B.G., et al. Non-invasive neurochemical analysis of focal excitotoxic lesions in models of neurodegenerative illness using spectroscopic imaging. J. Cereb. Blood Flow Metab. 16, 450– 461 (1996).
  Article CAS Google Scholar
• Guimareaeas, A.R. et al. Quantitative nuclear magnetic resonance spectroscopic imaging of neuronal loss in excitotoxic rat brain model. Neuroscience 69, 1093–1101 ( 1995).
  Google Scholar
• Arnold, D.L. et al. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann. Neurol. 36, 76–82 (1994).
  Article CAS Google Scholar
• Davies, C.A. et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 11, 49– 58 (1994).
  Article Google Scholar
• Birken, D.L. & Olendorf, W.H. N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of the brain. Neurosci. Biobehav. 1, 23– 31 (1989).
  Article Google Scholar
• Urenjak, J., Williams, S.R., Gadian, D.G. & Noble, M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 13, 981– 989 (1993).
  Article CAS Google Scholar
• Brownell, G.L. et al. Development in high-resolution positron emission tomography at MGH. Int. J. Imag. Sys. Technol. 1, 207 –17 (1989).
  Article Google Scholar
• Derenzo, S.E., Huesman, R.H. & Cahoon, J.L. A positron tomograph with 600 BGO crystals and 2.6 mm resolution. IEEE Trans. Nucl. Sci. NS-35, 659–664 (1988).
• Brownell, G.L., Burnham, C.A. & Chesler, D.A. in The Metabolism of the Human Brain Studied With Positron Emission Tomography, Ed. (eds. Greitz, T., Ingvar, D.H. & Widen, L.) 13–19 (Raven, New York, 1985).
  Google Scholar
• Bugiani, O., Perdelli, F., Salvarani, S., Leonardi, A. & Mancardi, G.L. Loss of striatal neurons in Parkinson's disease: a cytometric study. Eur. Neurol. 19, 339–344 (1980).
  Article CAS Google Scholar
• Hwang, J.H. et al. Short echo time proton magnetic resonance spectroscopic imaging of macromolecule and metabolite signal intensities in human brain. Magn. Reson. Med. 35, 633–639 (1996).
  Article CAS Google Scholar
• Frost, J.J. et al. Multicompartmental analysis of [11C]-carfentanil binding to opiate receptors in humans measured by positron emission tomography. J. Cereb. Blood Flow Metab. 9, 398– 409 (1989).
  Article CAS Google Scholar
• Kaufman, M.J. & Madras, B.K. Severe depletion of cocaine recognition sites associated with the dopamine transporter in parkinson's diseased striatum. Synapse 9 (1991).
• McNeil, T.H., Brown, S.A., Rafols, J.A. & Shoulson, I. Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease. Brain Res. 455, 148–152 (1988).
  Article Google Scholar
• Federico, F. et al. Proton magnetic resonance spectroscopy in parkinson's disease and atypical parkinsonian disorders. Mov. Disord. 12 , 903–909 (1997).
  Article CAS Google Scholar
• Clarke, C.E., Lowry, M. & Horsman, A. Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic parkinson's disease measured by protonmagnetic resonance spectroscopy. Mov. Disord. 12, 297–301 (1997).
  Article CAS Google Scholar
• Carvey, P. et al. Alterations in striatal neurotrophic activity induced by dopaminergic drugs. Pharmacol. Biochem. Behav. 46, 195–204 (1993).
  Article CAS Google Scholar
• Brownell, A.-L. et al. Cocaine congeners as PET imaging probes for dopamine terminals. J. Nucl. Med. 37, 1186– 1192 (1996).
  CAS PubMed Google Scholar
• Chesler, D.A. Positron emission tomography and three-dimensional reconstruction technique. Tomograph. Imag. Nuc. Med. 176–183 (1973).
• Foster, D.M. et al. SAAM II: simulation, analysis and modeling software. BMES Bull 18, 19–21 ( 1994).
  Google Scholar